These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6395283)

  • 61. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.
    Scott CF; Colman RW
    J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hematological prospect in 1981, particularly in the field of coagulation and fibrinolysis.
    Abe T
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):11-16. PubMed ID: 6810621
    [No Abstract]   [Full Text] [Related]  

  • 63. Complexes of Cl-inhibitor (Cl-INH) and hemostatic enzymes in normal plasma.
    Donaldson VH; Harrison RR
    Adv Exp Med Biol; 1983; 156():149-55. PubMed ID: 6602461
    [No Abstract]   [Full Text] [Related]  

  • 64. Plasma proteins and inflammatory disease.
    Cochrane CG
    Pharmacol Rev; 1982 Mar; 34(1):39-42. PubMed ID: 7041143
    [No Abstract]   [Full Text] [Related]  

  • 65. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.
    Rao AK; Schmaier AH; Colman RW
    Pathobiol Annu; 1982; 12():35-64. PubMed ID: 6186978
    [No Abstract]   [Full Text] [Related]  

  • 66. Assembly of contact-phase factors on the surface of the human neutrophil membrane.
    Henderson LM; Figueroa CD; Müller-Esterl W; Bhoola KD
    Blood; 1994 Jul; 84(2):474-82. PubMed ID: 8025275
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plasma activity of contact coagulation factors in patients with IgA nephritis.
    Tan CC; Lee GS; Lee EJ; Woo KT
    Ann Acad Med Singap; 1996 Mar; 25(2):218-21. PubMed ID: 8799009
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HMW and LMW kininogens.
    Kato H; Nagasawa S; Iwanaga S
    Methods Enzymol; 1981; 80 Pt C():172-98. PubMed ID: 7043190
    [No Abstract]   [Full Text] [Related]  

  • 69. Mediators of inflammation.
    Moore TL; Weiss TD
    Semin Arthritis Rheum; 1985 May; 14(4):247-62. PubMed ID: 3936177
    [No Abstract]   [Full Text] [Related]  

  • 70. [Clinical significance of the structure-function relation of hemostasis and kininogenesis].
    Chirkova LD
    Anesteziol Reanimatol; 1986; (3):64-9. PubMed ID: 2944444
    [No Abstract]   [Full Text] [Related]  

  • 71. [Determination of factor XII and plasma prekallikrein with chromozym PK].
    Stürzebecher J; Klessen C; Markwardt F
    Z Med Lab Diagn; 1982 Oct; 23(5):306-11. PubMed ID: 6924817
    [No Abstract]   [Full Text] [Related]  

  • 72. Enzymes of the contact phase of blood coagulation: kinetics with various chromogenic substrates and a two-substrate assay for the joint estimation of plasma prekallikrein and factor XI.
    Retzios AD; Rosenfeld R; Schiffman S
    J Lab Clin Med; 1988 Nov; 112(5):560-6. PubMed ID: 3263454
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cellular and subcellular mediators of acute inflammation.
    Solomkin JS; Simmons RL
    Surg Clin North Am; 1983 Apr; 63(2):225-43. PubMed ID: 6344271
    [No Abstract]   [Full Text] [Related]  

  • 74. Antigen levels of coagulation factor XII, coagulation factor XI and prekallikrein, and the risk of myocardial infarction and ischemic stroke in young women.
    Siegerink B; Rosendaal FR; Algra A
    J Thromb Haemost; 2014 May; 12(5):606-13. PubMed ID: 24977287
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein.
    Oh-ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I
    Tohoku J Exp Med; 1981 Jan; 133(1):67-80. PubMed ID: 6785899
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hyperprolactinemia and reduction in plasma titers of Hageman factor, prekallikrein, and high molecular weight kininogen in patients with acute myocardial infarction.
    La Follette L; Gordon EM; Mazur CA; Ratnoff OD; Yamashita TS
    J Lab Clin Med; 1987 Sep; 110(3):318-21. PubMed ID: 3649393
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prekallikrein activation, C1 esterase inhibitor, and factor XII as predictors of adverse reaction to contrast media. A prospective study.
    Hagan JJ; Yost FJ; Nickoloff EL
    Invest Radiol; 1987 Jun; 22(6):490-4. PubMed ID: 3497903
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.
    Bouma BN; Miles LA; Beretta G; Griffin JH
    Biochemistry; 1980 Mar; 19(6):1151-60. PubMed ID: 6768384
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation.
    Bouma BN; Kerbiriou DM; Vlooswijk RA; Griffin JH
    J Lab Clin Med; 1980 Oct; 96(4):693-709. PubMed ID: 6903191
    [No Abstract]   [Full Text] [Related]  

  • 80. Factors XI and XII and prekallikrein in sick and healthy premature infants.
    Andrew M; Bhogal M; Karpatkin M
    N Engl J Med; 1981 Nov; 305(19):1130-3. PubMed ID: 6912944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.